Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSCs) Engraft In Vivo and Support Hematopoiesis without Suppressing Immune Function: Implications for Off-The Shelf ES-MSC Therapies

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Li, Ou ^a   Tormin, Ariane ^a   Sundberg, Berit ^b   Hyllner, Johan ^c,d   Le Blanc, Katarina ^b   Scheding, Stefan ^a,e  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Arvid Wallgrens Backe 20   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD146 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HLA ANTIGEN; PHYTOHEMAGGLUTININ; THY 1 ANTIGEN; CYTOKINE;

ADIPOCYTE; ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CARTILAGE CELL; CELL ACTIVITY; CELL ASSAY; CELL COUNT; CELL DIFFERENTIATION; CELL HOMING; CELL TRANSPLANTATION; CELL TYPE; COLONY FORMING UNIT; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; OSTEOBLAST; STROMA; ANIMAL; BONE MARROW CELL; CLONOGENIC ASSAY; COMPARATIVE STUDY; CULTURE TECHNIQUE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; COLONY-FORMING UNITS ASSAY; CYTOKINES; EMBRYONIC STEM CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOPOIESIS; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE;

MLCS; MLOWN;

EID: 84873828780     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055319     Document Type: Article

References (50)

1. Charbord P, (2010) Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther 21: 1045-1056.
2. Sensebe L, Bourin P, (2009) Mesenchymal stem cells for therapeutic purposes. Transplantation 87: S49-53.
3. Mauney JR, Volloch V, Kaplan DL, (2005) Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11: 787-802.
4. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, et al. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441.
5. Paul D, Samuel SM, Maulik N, (2009) Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration. Antioxid Redox Signal 11: 1841-1855.
6. Bexell D, Gunnarsson S, Svensson A, Tormin A, Henriques-Oliveira C, et al. (2012) Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models. Neurosurgery 70: 731-739.
7. Bexell D, Gunnarsson S, Tormin A, Darabi A, Gisselsson D, et al. (2009) Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17: 183-190.
8. Hall B, Andreeff M, Marini F (2007) The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol: 263-283.
9. Bianco P, Robey PG, Simmons PJ, (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2: 313-319.
10. Friedenstein AJ, Chailakhjan RK, Lalykina KS, (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3: 393-403.
11. Salem HK, Thiemermann C, (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28: 585-596.
12. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, et al. (2002) Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46: 3349-3360.
13. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, et al. (2002) Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30: 783-791.
14. Larson BL, Ylostalo J, Prockop DJ, (2008) Human multipotent stromal cells undergo sharp transition from division to development in culture. Stem Cells 26: 193-201.
15. Tormin A, Brune JC, Olsson E, Valcich J, Neuman U, et al. (2009) Characterization of bone marrow-derived mesenchymal stromal cells (MSC) based on gene expression profiling of functionally defined MSC subsets. Cytotherapy 11: 114-128.
16. Mimeault M, Hauke R, Batra SK, (2007) Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82: 252-264.
17. Carpenter MK, Rosler E, Rao MS, (2003) Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5: 79-88.
18. Fenno LE, Ptaszek LM, Cowan CA, (2008) Human embryonic stem cells: emerging technologies and practical applications. Curr Opin Genet Dev 18: 324-329.
19. Karlsson C, Emanuelsson K, Wessberg F, Kajic K, Axell MZ, et al. (2009) Human embryonic stem cell-derived mesenchymal progenitors-Potential in regenerative medicine. Stem Cell Res 3: 39-50.
20. Bigdeli N, de Peppo GM, Lenneras M, Sjovall P, Lindahl A, et al. (2010) Superior osteogenic capacity of human embryonic stem cells adapted to matrix-free growth compared to human mesenchymal stem cells. Tissue Eng Part A 16: 3427-3440.
21. de Peppo GM, Sjovall P, Lenneras M, Strehl R, Hyllner J, et al. (2010) Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Eng Part A 16: 3413-3426.
22. Ahrens N, Tormin A, Paulus M, Roosterman D, Salama A, et al. (2004) Mesenchymal stem cell content of human vertebral bone marrow. Transplantation 78: 925-929.
23. Jones E, English A, Churchman SM, Kouroupis D, Boxall SA, et al. (2010) Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells. Arthritis Rheum 62: 1944-1954.
24. Tormin A, Li O, Brune JC, Walsh S, Schutz B, et al. (2011) CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 117: 5067-5077.
25. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O, (2003) Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57: 11-20.
26. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O, (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31: 890-896.
27. Mendez-Ferrer S, Frenette PS, (2007) Hematopoietic stem cell trafficking: regulated adhesion and attraction to bone marrow microenvironment. Ann N Y Acad Sci 1116: 392-413.
28. Muguruma Y, Yahata T, Miyatake H, Sato T, Uno T, et al. (2006) Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107: 1878-1887.
29. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A,et al. (1980) Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop Relat Res: 294-307.
30. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, et al. (1997) Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63: 1059-1069.
31. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, et al. (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586.
32. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
33. Pontikoglou C, Deschaseaux F, Sensebe L, Papadaki HA, (2011) Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev 7: 569-589.
34. Katsara O, Mahaira LG, Iliopoulou EG, Moustaki A, Antsaklis A, et al. (2011) Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 20: 1549-1561.
35. Phinney DG, (2007) Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy. Cell Cycle 6: 2884-2889.
36. Bernardo ME, Cometa AM, Pagliara D, Vinti L, Rossi F, et al. (2011) Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol 24: 73-81.
37. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
38. Tran TC, Kimura K, Nagano M, Yamashita T, Ohneda K, et al. (2011) Identification of human placenta-derived mesenchymal stem cells involved in re-endothelialization. J Cell Physiol 226: 224-235.
39. Chen XD, Qian HY, Neff L, Satomura K, Horowitz MC, (1999) Thy-1 antigen expression by cells in the osteoblast lineage. J Bone Miner Res 14: 362-375.
40. Papathanasopoulos A, Kouroupis D, Henshaw K, McGonagle D, Jones EA, et al. (2011) Effects of antithrombotic drugs fondaparinux and tinzaparin on in vitro proliferation and osteogenic and chondrogenic differentiation of bone-derived mesenchymal stem cells. J Orthop Res 29: 1327-1335.
41. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, et al. (2007) Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110: 2764-2767.
42. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, et al. (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18: 307-316.
43. Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, et al. (2002) Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 30: 870-878.
44. Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, et al. (2008) Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med 14: 181-187.
45. in 't Anker PS, Noort WA, Kruisselbrink AB, Scherjon SA, Beekhuizen W, et al. (2003) Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 31: 881-889.
46. Tolar J, Le Blanc K, Keating A, Blazar BR, (2010) Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 28: 1446-1455.
47. Gotherstrom C, Ringden O, Tammik C, Zetterberg E, Westgren M, et al. (2004) Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190: 239-245.
48. Gotherstrom C, Ringden O, Westgren M, Tammik C, Le Blanc K, (2003) Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 32: 265-272.
49. Li Y, Qu YH, Wu YF, Wang XP, Wei J, et al. (2011) Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice. Ann Hematol 90: 873-885.
50. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, et al. (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102: 3837-3844.